# DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)

> **NCT01017224** · — · COMPLETED · sponsor: **University of Aarhus** · enrollment: 40 (actual)

## Conditions studied

- Cancer of the Head and Neck

## Interventions

- **OTHER:** 18F-FAZA

## Key facts

- **NCT ID:** NCT01017224
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2012-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017224, "DAHANCA 24: Prognostic Value of 18F-FAZA in Head and Neck Squamous Cell Carcinoma (HNSCC)". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT01017224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*